Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial.
Ochenduszko S, Puskulluoglu M, Konopka K, Fijorek K, Urbanczyk K, Budzynski A, Matlok M, Lazar A, Sinczak-Kuta A, Pedziwiatr M, Krzemieniecki K. Ochenduszko S, et al. Among authors: puskulluoglu m. Med Oncol. 2015 Oct;32(10):242. doi: 10.1007/s12032-015-0687-7. Epub 2015 Sep 9. Med Oncol. 2015. PMID: 26354521 Free PMC article. Clinical Trial.
Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature.
Streb J, Püsküllüoğlu M, Glanowska I, Ochenduszko S, Konopka K, Łupkowski R, Michalowska-Kaczmarczyk A, Bochenek-Cibor J, Majka M, Krzemieniecki K. Streb J, et al. Among authors: puskulluoglu m. Oncol Lett. 2015 Dec;10(6):3749-3755. doi: 10.3892/ol.2015.3800. Epub 2015 Oct 12. Oncol Lett. 2015. PMID: 26788202 Free PMC article.
Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study.
Ochenduszko S, Puskulluoglu M, Konopka K, Fijorek K, Slowik AJ, Pędziwiatr M, Budzyński A. Ochenduszko S, et al. Among authors: puskulluoglu m. Ther Adv Med Oncol. 2017 Apr;9(4):223-233. doi: 10.1177/1758834016689029. Epub 2017 Feb 7. Ther Adv Med Oncol. 2017. PMID: 28491144 Free PMC article.
42 results